Chongqing Laimei Pharmaceutical Co., Ltd. was established in 1999

In p>2, large-capacity injections passed GMP certification. The company's first product was produced and listed

in 21, it was recognized as a "high-tech enterprise" in Chongqing by Chongqing Municipal Science and Technology Commission

in 21 and 22, it was rated as "Top Ten Industrial Enterprises in Jiangbei District"

In 22, it passed GMP certification

Since 22, it has been rated as "Advanced Enterprise of Honesty and Tax Payment in Chongqing" for many times

In p>24, it moved to Chongqing. And passed GMP certification as a whole

In p>25, the global exclusive tumor tracer was successfully listed

In p>26, freeze-dried powder injection (anti-tumor and hormone) and powder injection passed GMP certification, and 1 raw materials passed GMP certification respectively

In p>27, Chongqing Science and Technology Venture Capital Company, an excellent investment institution ranked among the top 5 in China, invested in Laimei Pharmaceutical. Become a strategic partner of the company

In 27, the company successfully reformed and established a joint-stock company-"Chongqing Laimei Pharmaceutical Co., Ltd."

In 27, it was named "Top Ten Innovative High-tech Enterprises in Chongqing"

In 27, it was recommended by the Municipal Finance Office as a key company to be listed in Chongqing

In 28, the tablet passed GMP certification

In 28, it was named "Chongqing Famous Trademark". Brand listing (stock code: 36)

In 29, it was rated as "Top Ten Innovative High-tech Enterprises in Chongqing in 28-29"

In p>27, it was recommended by the Municipal Finance Office as a key company to be listed in Chongqing

In 28, the tablet passed GMP certification

In 29, it was listed on the Growth Enterprise Market of Shenzhen Stock Exchange (stock code: 3) Public offering of RMB ordinary shares (A shares: 23 million shares

acquisition of Chongqing Dashanhang Chinese Herbal Pieces Co., Ltd. (renamed as Chongqing Laimei Mouse Chinese Herbal Pieces Co., Ltd.) in p>p>21

acquisition of Hunan Kangyuan Pharmaceutical Co., Ltd.

acquisition of Sichuan Hezheng Pharmaceutical Co., Ltd. in p>211.